Merck KGaA ADR
USUSDMerck KGaA ADR (VI:MRK) — Biotechnology: Pharmaceutical Preparations. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 6. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.
- Merck KGaA — MRK · XETRA DE Registrierungsnummer unbekannt
Über das Unternehmen
- Website
- merck.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hauptsitz
- RAHWAY, Germany
- CEO
- Dr. Kai Beckmann
- Mitarbeiter
- 62 136
- Ausstehende Aktien
- 2.47 Mrd. Stand 2026-07-31
- Streubesitz
- 644.35 Mio.
- Marktkapitalisierung
- 67.93 Mrd. USD
- Insider
- 0%
- Institutionelle Anleger
- 0.02%
- Branche (SIC)
- Pharmaceutical Preparations
- Rechtsform
- XSNP
- ISIN
- US58933Y1055
- LEI
- 4YV9Y5M8S0BRK1RP0397
- Ausschüttungsquote
- 262%
- FCF
- 16.1 Mrd. USD52%
- Schulden
- 53.9 Mrd. USD2.9 J. FCF
- Dividendenserie
- 56+ J.
- Gewinn, FCF und gezahlte Dividenden — für die 12 Monate bis 30.06.2026 (letzter Bericht des Unternehmens).
Beschreibung
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Börsen und Ticker
| Börse | Ticker | Währung | Preis | Typ |
|---|---|---|---|---|
| US USA Stocks | MRK zusätzlich | USD | 142.38 -0.29% | Stammaktie |
| LSE London Stock Exchange | 0QAH IOB | USD | 148.65 -0.12% | Stammaktie |
| MI Borsa Italiana (Milan) | 1MRKX primär | EUR | 125.06 -2.69% | Stammaktie |
| MX Mexican Stock Exchange | MRK zusätzlich | MXN | 2 561 +0.91% | Stammaktie |
| VI Vienna Stock Exchange | MRK zusätzlich | EUR | 129.76 | Stammaktie |
| XETRA Xetra | 6MK zusätzlich | EUR | 129.78 +0.09% | Stammaktie |
Dividenden
Merck KGaA ADR (MRK) zahlt vierteljährlich Dividenden. In den letzten 12 Monaten wurde 3.4 USD pro Aktie gezahlt (Zahlungen: 4). Das entspricht etwa 2.39% des aktuellen Aktienkurses. Basierend auf der Zahlungshistorie wird der nächste Ex-Dividenden-Tag um den 15.12.2026 erwartet. Ununterbrochene Dividendengeschichte: 56 Jahre.
| Ex-Tag | Auszahlung | Betrag | % | Typ | Ticker |
|---|---|---|---|---|---|
| 2026-09-15 | 2026-10-07 | 0.8500 USD | 0.6/2.4 % | vierteljährlich | US:MRK |
| 2026-06-15 | 2026-07-08 | 0.8500 USD | 0.6/2.4 % | vierteljährlich | US:MRK |
| 2026-03-16 | 2026-04-07 | 0.8500 USD | 0.6/2.3 % | vierteljährlich | US:MRK |
| 2025-12-15 | 2026-01-08 | 0.8500 USD | 0.6/2.3 % | vierteljährlich | US:MRK |
| 2025-09-15 | 2025-10-07 | 0.8100 USD | 0.6/≈2.3 % | vierteljährlich | US:MRK |
| 2025-06-16 | 2025-07-08 | 0.8100 USD | 0.6/≈2.3 % | vierteljährlich | US:MRK |
| 2025-03-17 | 2025-04-07 | 0.8100 USD | 0.6/≈2.3 % | vierteljährlich | US:MRK |
Neuigkeiten diese Woche
Noch keine Nachrichten von der Website des Unternehmens.
Größte Anteilseigner
| Inhaber | Anteil | Aktien | Berichtsdatum |
|---|---|---|---|
| BlackRock | 9.2% | 227 Mio. | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 161.32 Mio. | 2026-06-30 |
| State Street Corporation | 4.88% | 120.41 Mio. | 2026-06-30 |
| Wellington Management Gr… | 3.5% | 86.25 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 78.41 Mio. | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.75% | 67.74 Mio. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 64 Mio. | 2026-06-30 |
| Geode Capital Management… | 2.46% | 60.74 Mio. | 2026-06-30 |
| Charles Schwab Investmen… | 2.2% | 54.37 Mio. | 2026-06-30 |
| Morgan Stanley | 1.97% | 48.64 Mio. | 2026-06-30 |
| FMR, LLC | 1.84% | 45.44 Mio. | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.78% | 43.89 Mio. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.33% | 32.89 Mio. | 2026-08-31 |
| Fidelity Concord Street… | 1.29% | 31.94 Mio. | 2026-07-31 |
| SCHWAB STRATEGIC TRUST-S… | 1.25% | 30.86 Mio. | 2026-05-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 30.22 Mio. | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 23.51 Mio. | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.75 Mio. | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.65% | 15.95 Mio. | 2026-07-31 |
| VANGUARD SPECIALIZED FUN… | 0.57% | 13.97 Mio. | 2026-07-31 |
| DAVIS ROBERT M (Chief Ex… | ≈0.02% | 450 351 | 2026-04-29 |
| CHATTOPADHYAY SANAT (Off… | ≈0.01% | 200 675 | 2026-04-29 |
| DELUCA RICHARD ROBERT JR… | ≈0% | 110 167 | 2026-08-12 |
| LI DEAN Y (Officer) | ≈0% | 94 431 | 2026-04-29 |
| LITCHFIELD CAROLINE (Chi… | ≈0% | 92 300 | 2026-04-29 |
| ZACHARY JENNIFER L (Gene… | ≈0% | 45 509 | 2026-08-12 |
| GUINDO CHIRFI (Officer) | ≈0% | 36 613 | 2026-08-13 |
| WILLIAMS DAVID MICHAEL (… | ≈0% | 31 716 | 2026-08-05 |
| ROMANELLI JOSEPH EDWARD… | ≈0% | 28 739 | 2026-01-26 |
| OOSTHUIZEN JOHANNES JACO… | ≈0% | 21 895 | 2026-04-29 |
| Trust for Professional M… | 0% | 24 803 | 2026-05-31 |
| Rhumbline Advisers | 0% | 10 919 | 2026-06-30 |
| SP Funds Trust-SP Funds… | 0% | 6 542 | 2026-07-31 |
| Atlas Capital Advisors I… | 0% | 2 467 | 2026-06-30 |
| Gamma Investing LLC | 0% | 2 302 | 2026-06-30 |
| Salomon & Ludwin, LLC | 0% | 356 | 2026-06-30 |
| PNC Financial Services G… | 0% | 2 | 2026-06-30 |
| The Vanguard Group | — | — | — |
